Table 5 Combination of PET/MRI features as well as the ADC allows differentiation between chemotherapy responders and non-responders with high sensitivity and specificity
From: [18F]FDG PET/MRI enables early chemotherapy response prediction in pancreatic ductal adenocarcinoma
| Â | Cut-off value | ROC-AUC | Sensitivity | Specificity |
|---|---|---|---|---|
∆TLG 50% *∆ADC max | 0 | 0.86 | 0.92 | 0.8 |
∆SUVmax *∆MTV50% | 0 | 1.00 | 1.00 | 1.00 |
∆SUVmax *∆TLG 50% | 0 | 0.86 | 0.92 | 0.80 |
∆MTV50% *∆ADC max | 0.10 | 1.00 | 1.00 | 1.00 |